Stemina Biomarker Discovery Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 14
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $211K
Latest Deal Amount
  • Investors
  • 9

Stemina Biomarker Discovery General Information

Description

Developer of molecular biomarkers designed to perform diagnosis and treat neurological disorders, including autism spectrum disorders. The company's biomarkers offer drug screening service that uses human embryonic stem cells to screen drugs, chemicals, consumer products, and cosmetics for their potential effect on the developing human embryo, enabling physicians to avail insight into human responses in physiologically relevant tissue.

Contact Information

Website
www.stemina.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 504 South Rosa Road
  • Suite 150
  • Madison, WI 53719
  • United States
+1 (608) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Stemina Biomarker Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Debt - PPP 06-Apr-2020 $211K 000.00 Completed Generating Revenue
12. Equity Crowdfunding 23-Jan-2018 0000 Cancelled Generating Revenue
11. Later Stage VC 06-Jun-2016 00.000 000.00 Completed Generating Revenue
10. Grant 23-Sep-2015 00.00 000.00 Completed Generating Revenue
9. Later Stage VC 12-Jan-2015 00.00 000.00 Completed Generating Revenue
8. Grant 01-Jan-2015 00.00 000.00 Completed Generating Revenue
7. Later Stage VC (Series B) 19-Nov-2014 000 000.00 0000 Completed Generating Revenue
6. Later Stage VC (Series A2) 01-Jan-2013 00000 00.000 000.00 Completed Generating Revenue
5. Grant 01-Jan-2012 $147K $3M Completed Generating Revenue
4. Grant 01-Jan-2011 $500K $3M Completed Generating Revenue
To view Stemina Biomarker Discovery’s complete valuation and funding history, request access »

Stemina Biomarker Discovery Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 478,382 $0.001000 8% $6.27 $6.27 1x $6.27 13.87%
To view Stemina Biomarker Discovery’s complete cap table history, request access »

Stemina Biomarker Discovery Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular biomarkers designed to perform diagnosis and treat neurological disorders, including autism spect
Drug Discovery
Madison, WI
14 As of 2020
000.00
000000000 - 000.00

00000000

onsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nul
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000 000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
0000 000000000
San Diego, CA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stemina Biomarker Discovery Competitors (61)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AavantiBio Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
0000000 0000000000 Venture Capital-Backed Niel, Belgium 00 000.00 00000000000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Redwood City, CA 000 00000 00000000000 00000
You’re viewing 5 of 61 competitors. Get the full list »

Stemina Biomarker Discovery Patents

  • 52

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Stemina Biomarker Discovery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210072230-A1 In vitro assay to predict cardiotoxicity Pending 09-Mar-2018 00000000000
EP-3762715-A1 In vitro assay to predict cardiotoxicity Pending 09-Mar-2018 00000000000
US-20200348319-A1 Diagnosis and treatment of autism spectrum disorders based on amine containing metabotypes Pending 29-Jan-2018 00000000000
EP-3746796-A1 Diagnosis and treatment of autism spectrum disorders based on amine containing metabotypes Pending 29-Jan-2018 00000000000
US-20190178900-A1 Autism subsets Pending 13-May-2016 G01N33/6896
To view Stemina Biomarker Discovery’s complete patent history, request access »

Stemina Biomarker Discovery Executive Team (3)

Name Title Board Seat Contact Info
Elizabeth Donley JD Co-Founder, Chief Executive Officer & Board Member
Robert Burrier Ph.D Chief Operating Officer, Board Member, Vice President, Research & Development & Advisor
You’re viewing 2 of 3 executive team members. Get the full list »

Stemina Biomarker Discovery Board Members (12)

Name Representing Role Since
Andrew Ferrara Self Board Member 000 0000
Anthony Shuber Self Board Member 000 0000
Barbara Handelin Self Board Member 000 0000
Donnie Hardison Self Board Member 000 0000
Elizabeth Donley JD Stemina Biomarker Discovery Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Stemina Biomarker Discovery Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stemina Biomarker Discovery Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wisconsin Alumni Research Foundation Venture Capital Minority 000 0000 000000 0
National Institutes of Mental Health Government 000 0000 000000 0
BrightStar Wisconsin Foundation Venture Capital Minority 000 0000 000000 0
DaneVest Capital Venture Capital Minority 000 0000 000000 0
Jeffrey Rusinow Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial